Semax is a synthetic heptapeptide based on the ACTH(4-10) fragment, incorporating a C-terminal Pro-Gly-Pro extension that modulates its stability and functional profile. Published neuroscience research has characterized this compound’s interactions with neurotrophic factor expression, particularly its documented effects on BDNF and NGF transcript levels in neuronal cell culture systems.
The compound has been referenced in published studies examining neuropeptide signaling, synaptic plasticity mechanisms, and cognitive-associated molecular pathways. Researchers have documented semax’s effects on immediate early gene expression, neurotransmitter metabolism, and cerebrovascular dynamics in various experimental paradigms reported in the neuropharmacology literature.
Each 10mg vial contains lyophilized semax with verified sequence identity and purity. The preparation is manufactured under controlled conditions suitable for sensitive neurobiological research applications.
For in-vitro and preclinical research only. Not approved for human or veterinary use.
